Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new nolvadex clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on nolvadex
- Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Status: Recruiting, Condition Summary: Breast Cancer - Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
Status: Recruiting, Condition Summary: Desmoid Tumor - Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
Status: Active, not recruiting, Condition Summary: Breast Cancer - PROACT - Pre-Operative Arimidex Compared To Tamoxifen
Status: Completed, Condition Summary: Breast Cancer - Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
Status: Recruiting, Condition Summary: Breast Cancer; Depression; Hot Flashes; Psychosocial Effects/Treatment - Casodex - Nolvadex Combination
Status: Completed, Condition Summary: Gynaecomastia; Prostate Cancer - A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer
Status: Completed, Condition Summary: Breast Cancer; Metastasis - Randomized Phase III Study of Exemestane (Aromasin) for 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed by Exemestane
Status: Active, not recruiting, Condition Summary: Breast Neoplasms - Cognition in the Study of Tamoxifen and Raloxifene
Status: Completed, Condition Summary: Cognition; Aging - Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer
Status: Active, not recruiting, Condition Summary: Breast Cancer - Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ
Status: Recruiting, Condition Summary: Breast Cancer - Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen
Status: Recruiting, Condition Summary: Breast Cancer - Tipifarnib Plus Tamoxifen in Treating Women With Metastatic Breast Cancer
Status: Completed, Condition Summary: Breast Cancer - Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer
Status: Active, not recruiting, Condition Summary: Breast Cancer - Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
Status: Recruiting, Condition Summary: Intraocular Melanoma - CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen
Status: Recruiting, Condition Summary: Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer - Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
Status: Completed, Condition Summary: Adrenocortical Carcinoma; Brain and Central Nervous System Tumors; Head and Neck Cancer; Liver Cancer; Malignant Mesothelioma; Pheochromocytoma; Sarcoma - Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
Status: Completed, Condition Summary: Breast Cancer - Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer
Status: Active, not recruiting, Condition Summary: Breast Cancer - Tamoxifen in Treating Patients With Primary Liver Cancer
Status: Active, not recruiting, Condition Summary: Liver Cancer - Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer
Status: Active, not recruiting, Condition Summary: Breast Cancer - Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma
Status: Active, not recruiting, Condition Summary: Brain and Central Nervous System Tumors - Tamoxifen in Treating Women With Breast Cancer
Status: Active, not recruiting, Condition Summary: Breast Cancer - Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast Cancer
Status: Active, not recruiting, Condition Summary: Breast Neoplasms - Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer
Status: Recruiting, Condition Summary: Breast Cancer - Tamoxifen and Bortezomib in Treating Patients With Recurrent Gliomas
Status: Recruiting, Condition Summary: Brain and Central Nervous System Tumors - Examination of Tamoxifen in Acute Mania in Patients With Bipolar I Disorder
Status: Completed, Condition Summary: Bipolar Disorder - Cognitive Aging - STAR
Status: Completed, Condition Summary: Breast Cancer - Tamoxifen Pharmacogenetics and Clinical Effects
Status: Completed, Condition Summary: Breast Cancer - Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment
Status: Recruiting, Condition Summary: Breast Cancer